Hong Kong Med J 2017 Apr;23(2):150–7 | Epub 24 Feb 2017
DOI: 10.12809/hkmj164993
ORIGINAL ARTICLE
Mothers’ attitude to the use of a combined oral contraceptive pill by their daughters for menstrual disorders or contraception
KW Yiu, MRCOG, FHKAM (Obstetrics and Gynaecology); Symphorosa SC Chan, FRCOG, FHKAM (Obstetrics and Gynaecology); Tony KH Chung, FRANZCOG, FRCOG
Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong
 
Corresponding author: Dr Symphorosa SC Chan (symphorosa@cuhk.edu.hk)
 
 Full paper in PDF
 
Abstract
Introduction: Mothers’ attitude may affect use of combined oral contraceptive pills by their daughters. We explored Chinese mothers’ knowledge of and attitudes towards the use of combined oral contraceptive pills by their daughters for menstrual disorders or contraception, and evaluate the factors affecting their attitude.
 
Methods: This survey was conducted from October 2012 to March 2013, and recruited Chinese women who attended a gynaecology clinic or accompanied their daughter to a gynaecology clinic, and who had one or more daughters aged 10 to 18 years. They completed a 41-item questionnaire to assess their knowledge of and attitude towards use of the combined oral contraceptive pills by their daughters. The demographic data of the mothers and their personal experience in using the pills were also collected.
 
Results: A total of 300 women with a mean age of 45.2 (standard deviation, 5.0) years completed the questionnaire. Only 58.3% of women reported that they had knowledge about the combined oral contraceptive pills; among them, a majority (63.3%) reported that their source of knowledge came from medical professionals. Of a total possible score of 22, their mean knowledge score for risk, side-effects, benefits, and contra-indications to use of combined oral contraceptive pills was only 5.0 (standard deviation, 4.7). If the medical recommendation to use an oral contraceptive was to manage their daughter’s dysmenorrhoea, menorrhagia, acne, or contraception needs, 32.0%, 39.3%, 21.0% and 29.7%, respectively would accept this advice. Women who were an ever-user of combined oral contraceptive pills or who were more knowledgeable about combined oral contraceptives had a higher acceptance rate.
 
Conclusions: Chinese women had a low acceptance level of using combined oral contraceptive pills as a legitimate treatment for their daughters. This was associated with lack of knowledge or a high degree of uncertainty about their risks and benefits. It is important that health caregivers provide up-to-date information about combined oral contraceptive pills to women and their daughters.
 
 
New knowledge added by this study
  • Chinese women had a low acceptance level of combined oral contraceptive (COC) pills as a legitimate treatment for their daughters. This was associated with lack of knowledge or a high degree of uncertainty about the risks and benefits of COC use.
Implications for clinical practice or policy
  • Health caregivers should provide up-to-date information to potential COC users.
 
 
Introduction
The combined oral contraceptive (COC) pill is an effective contraception. It has a very low-risk profile documented over several decades and its protective effect on endometrial and ovarian carcinoma has been well established.1 It is also an effective treatment for menstrual problems and polycystic ovarian syndrome,2 3 which are common in adolescents.4 5 6 7 The prevalences of menorrhagia, dysmenorrhoea, and menstrual symptoms in adolescent girls have been reported to be 17.9%, 68.7%, and 37.7%, respectively.4 The prevalence of polycystic ovarian syndrome in adolescent girls has been reported to be 16% in those who attended a local paediatric and adolescent gynaecology clinic.5 Nonetheless, the use of COC pills in Chinese women has remained low; only 1% of women of reproductive age (20-49 years) in China used the pills in 2010.8 There are some obstacles to access although family planning is a relatively well-funded area of health care in China and has been implemented for decades. In Hong Kong, the situation is slightly less unusual. From an online survey conducted in Hong Kong, 12.6% of women had used an oral contraceptive in the year prior to the survey, but many of them had stopped using it.9 According to the annual report of the Family Planning Association of Hong Kong in 2014-2015, 22% of the 48 363 clients who practised birth control, including women who were both married and unmarried, used an oral contraceptive.10 Only 6% of teenage girls who attended the youth health care centres used COC pills for contraception.11
 
Although sex education has been integrated into the primary and secondary educational curriculum for many years, efforts to provide quality sex education have been limited.12 According to a survey conducted by the Hong Kong SAR Government, sex education at the junior secondary school level is limited to an average of 3 to 4 school hours only.13 Sometimes concepts emphasised included protection of self and avoidance of sex, especially prior to marriage.14 The median age of marriage in Hong Kong is now close to 30 years. It is notable that Hong Kong has a high rate of therapeutic abortion that is underestimated by official statistics because an indeterminate proportion is performed in mainland China due to cost considerations. In women attending for their antenatal visit, a high proportion of 36.5% reported a previous therapeutic abortion (unpublished data from our institute). This suggests that women of reproductive age may not have been educated about contraception. There is little published information on the use of COC pills for the management of menstrual problems in Hong Kong but it is likely to be low. Misconceptions and myths about COC pills are likely to be the main obstacles to use. Although extensive high-quality information about use of COC is currently available from various sources, many women remain unaware of the non-contraceptive benefits of COC. They also have little awareness of the risks of COC.15 For female adolescents, their decision about whether to use COC is likely to be influenced by their parents, especially their mothers, who may be giving advice to their daughters based on little or erroneous knowledge. This may lead mothers to make decisions that are not in their daughter’s best interests.
 
Focused education about COC may lead to a more balanced view, both in adolescents and their mothers. In a study of Korean and Japanese university students, significant correlation between knowledge of and positive attitude towards COC pills was reported.16 Mothers in Asia are also often involved in their teenage daughters’ decision to begin sexual relationships, the use of contraceptives, and even vaccination.17 18 Since the mothers’ attitude may affect use of COC by their daughters, we explored Chinese mothers’ knowledge of and attitudes towards such use. Mothers’ knowledge about the COC pills and factors affecting their attitude were also evaluated.
 
Methods
The study was conducted from October 2012 to March 2013 in the gynaecology clinic of a tertiary teaching hospital in Hong Kong. Women who attended the clinic or accompanied a daughter to the clinic, and who had one or more daughters aged 10 to 18 years were recruited. Women who did not speak or read Chinese were excluded. The participants completed a 41-item questionnaire to assess their knowledge of and attitude towards use of COC pills by their daughters. Firstly, they were asked to self-assess their own knowledge of the COC pill. The knowledge domain consisted of 19 items testing their knowledge of the non-contraceptive health benefits and side-effects of COC pills, and three items on contra-indications to use of COC pills. For each item, participants were asked to respond “yes”, “no”, or “don’t know”. They were then asked about their attitudes to the use of COC pills by their daughters aged 10 to 18 years for the management of dysmenorrhoea, menorrhagia, acne, or as a contraceptive. They were asked to respond from “strongly agree”, “agree”, “disagree”, to “strongly disagree”. Reasons for agreeing or disagreeing with the use of COC pills and the appropriate age or life-events for using COC pills by their daughters were also asked. Finally, demographic data and their personal experience in using COC pills were collected. Knowledge score and uncertainty score were calculated for the participants based on their response15 16—knowledge score was defined as the score of correct answers with 1 score given for each correct answer (ie range from 0-22); a “don’t know” reply would create the uncertainty score. The participants provided written informed consent, and approval was obtained from the local ethics committee (CRE-2012.186).
 
Statistical analyses
Descriptive statistics were used to summarise participants’ demographic information. Association between participant characteristics and overall attitude was explored using Chi squared and independent-samples t test. A P value of <0.05 was considered statistically significant. All statistical analyses were conducted using the SPSS (Windows version 18.0; SPSS Inc, Chicago [IL], United States). Assuming that 50% of the women accepted the use of COC pills by their daughters with an accepted error of 0.05%, 278 women were required. An additional 10% was recruited to prepare for an incomplete questionnaire.
 
Results
Apart from 150 women who were excluded because they did not have a daughter aged 10 to 18 years, a total of 317 women were invited to participate; 302 agreed and 300 (94.6%) completed the questionnaire. Demographic characteristics of the participants are shown in Table 1. Their mean age was 45.2 years (range, 28-58 years). The median number of daughters was one and most participants (88.3%) were married. Most (>70%) had high school education. In all, 125 (41.7%) were ever-users of COC pills, including both current and ex-users. Overall, 175 (58.3%) reported that they had knowledge about the COC pills, while 125 (41.7%) reported no knowledge.
 

Table 1. Demographics of the participants
 
The rates of giving correct answers about the COC pill and the comparison between ever- and never-users of COC pills are shown in Table 2. Of a total possible score of 22, the mean (± standard deviation) knowledge score of all the participants was 5.0 ± 4.7. Of all the participants, only approximately 20% of the mothers correctly answered that COC pills would not cause carcinoma of ovary and corpus; 26.0%, 29.7%, and 30.3% respectively correctly answered that COC pills did not have proven teratogenicity, cause pelvic inflammatory disease and infertility; 10.3% knew that COC pills would not cause weight gain and 25.7% answered that COC pills would not lead to a depressive mood. In all, 43.3%, 33.0%, and 25.3% knew that COC pills had the benefits of regulating the menstrual cycle, decreasing menstrual flow, and helping to relieve dysmenorrhoea, respectively. Moreover only 20% knew that the COC pills are not contra-indicated in people with a family history of breast cancer but is contra-indicated in thromboembolism. The knowledge score of the 175 women who responded to have knowledge of the COC pills was significantly higher than those who reported lack of knowledge (8.0 ± 4.4 vs 3.0 ± 3.7; P<0.001). Among those who declared they had knowledge about the use of COC pills, their sources of knowledge were from medical professional (63.3%), media (30.3%), friends (24.6%), family members (6.9%), school (2.9%), and others (1%).
 

Table 2. Rates of giving correct answers about COC and comparison between ever- and never-users of COC pills
 
The rate of responding “uncertain” to the health benefit, side-effects, or contra-indications of COC use ranged from 43.7% to 71.0% for each item. The mean uncertainty score among all participants was 13.0 ± 7.6. The uncertainty score was significantly higher in participants who reported to have lack of knowledge when compared with those reported to have knowledge about COC pills (15.6 ± 7.1 vs 9.1 ± 6.7; P<0.001).
 
Among the ever-users, 43 (34%), five (4%), and 96 (77%) women reported that COC pills had been used to manage their own menstrual problems, acne problems, and as contraception, respectively. Table 3 lists the participants’ acceptance rate of COC use by their daughters in different gynaecological conditions and the comparison between ever- and never-users of COC pills. More ever-users than never-users accepted the use of COC for their daughter’s gynaecological indications. Participants who accepted their daughter’s use of COC also had a higher knowledge score and lower uncertainty score (Table 4). Table 5 shows the participants’ reasons for accepting use of COC pills by their daughters. Recommendation by medical professionals was the major reason, followed by the knowledge that COC pills provided effective contraception.
 

Table 3. Participants’ acceptance of COC use by their daughters for different gynaecological conditions and comparison between ever- and never-users of COC pills
 

Table 4. Comparison of the knowledge score and uncertainty score in participants who agreed or disagreed with the use of COC pills by their daughters under different gynaecological conditions
 

Table 5. Participants’ reasons for accepting use of COC pills by their daughters for menstrual problems
 
Age, education level, and whether they had previous experience of side-effects of COC pills were not associated with participants’ acceptance of COC use by their daughters. Among the 125 ever-users of COC pills, 65 (52.0%) reported they had experienced side-effects, including weight gain (n=45), fluid retention (n=25), headache (n=12), increase in appetite (n=8), mode disturbance (n=8), and acne (n=4). Table 6 lists the reasons for disagreement with the use of COC pills by their daughters for menstrual problems. Finally, only 71 (23.6%) participants thought that the use of COC pills was appropriate in girls aged 12 to 18 years.
 

Table 6. Participants’ reasons for disagreement with the use of COC pills by their daughters for menstrual problems
 
Discussion
Our study highlights a notable lack of knowledge about the use of COC pills in many Hong Kong Chinese mothers. Many were uncertain or had erroneous beliefs about the use of COC pills. They believed that such usage would lead to cancers, fetal deformity, and cause infertility and pelvic inflammatory disease. These misconceptions and uncertainties may further reinforce their non-acceptance of the COC pills as an appropriate medication for their daughters. This inevitably often leads to suboptimal treatment for their daughters.
 
Fear of increased risk of cancer is an important reason for low acceptance of COC pills and only 22% of our participants thought it did not increase the risk for carcinoma of ovary or uterus. More than 60% of the participants were uncertain about the risk of cancer with the use of COC pills (results not shown). Research has shown that contraceptives have a significantly protective effect on carcinoma of ovary and corpus uteri.19 20 In fact, a collaborative re-analysis of individual data from 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies revealed that while women were taking COC pills and in the 10 years after stopping, there was a small increase in the relative risk of breast cancer.21 There was, however, no significant excess risk of having breast cancer diagnosed ≥10 years after stopping use of COC pills. The breast cancer incidence rises steeply with age. The estimated excess number of cancers diagnosed in the period between starting use and 10 years after stopping increases with age at last use. The estimated excess number of breast cancers diagnosed up to 10 years after stopping use from the age of 16 to 19 years among 10 000 women has been reported to be 0.5 (95% confidence interval, 0.3-0.7) only.21 The Nurses’ Health Study with 121 701 participants followed up for 36 years revealed that longer duration of COC use was strongly associated with premature mortality due to breast cancer.22 Another highlight was that only 20.7% of our participants knew that a family history of breast cancer was not a contra-indication to use of COC pills.
 
Another common misconception is that the use of COC pills can lead to future subfertility. The COC pill preserves fertility by diminishing the risk of ectopic pregnancy.23 According to a review, 1-year pregnancy rates after discontinuation of COC ranged from 79% to 96%, similar to those reported following discontinuation of barrier methods or no contraception.24 Moreover, the progestogen effect of COC pills results in production of thick, tenacious cervical mucus that resists penetration by bacteria and spermatozoa and reduces the risk of upper genital tract infection. Use of COC pills was also quoted to be protective against symptomatic pelvic inflammatory disease, with a 50% reduction in rate of hospitalisation for the disease, with itself being a risk factor for subfertility.25 The COC pill does not protect against sexually transmitted infections. On the other hand, there is no evidence to support the notion that the use of COC pills is associated with high-risk sexual behaviour in adolescents, which is a very common fear among Hong Kong mothers.
 
Primary dysmenorrhoea is prevalent during adolescence. Approximately 6.4% of adolescents or 29% of those reporting severe dysmenorrhoea seek help from a physician.4 A review and meta-analysis of five trials of the use of COC pills concluded that it was more effective than placebo in managing dysmenorrhoea.2 One of the most common problems reported by adolescents is irregular and/or profuse menstruation. The COC pill is also effective in treating and preventing heavy menstrual bleeding. In our study, only 25% to 43% of the participants knew that it is an appropriate treatment for menstrual problems and 50% were uncertain.
 
The fear of side-effects often leads to reluctance to using new treatments.18 In many cases, such fears are often unfounded. In our study, participants believed that weight gain and depressive mood were side-effects of COC pills, although pooled analysis of a placebo-controlled trial showed no difference in weight gain.26 Furthermore, depressive symptoms are common in adolescence.27 In a randomised controlled study, there was no difference in mood changes throughout the menstrual cycle between COC users and non-users.28 In a prospective study of 43 adolescents, subjects anticipated more side-effects than they actually experienced after 6 months of taking COC pills.29
 
It is important to provide correct information to women and their teenage daughters if they are contemplating the use of COC pills. In our study, 40% of participants indicated that recommendation from a medical professional was a critical factor in their acceptance of the use of COC pills by their daughters.
 
Only 19% of participants were aware that thromboembolism is a contra-indication to COC use. Venous thromboembolism in Asians has been reported to be low.30 A recent case-control study confirmed that current exposure to any COC poses a 3-times higher risk of venous thromboembolism compared with no exposure in the previous year.31 The risk is higher with COC pills containing desogestrel (odds ratio, 4.3), gestodene (3.6), drospirenone (4.1), and cyproterone (4.3) than the second-generation COC pills with levonorgestrel (2.4) and norgestimate (2.5).31 The risk of venous thromboembolism is also increased for COC users with a family history of venous thromboembolism.32 Clinicians should assess the woman’s personal and family history of thromboembolism, and provide information about the warning symptoms of venous thromboembolism before prescribing a new generation pill. As recommended by the World Health Organization, the COC pill is not contra-indicated in smokers <35 years old33; approximately 30% of our participants answered this correctly.
 
This study has several limitations. First, there may be selection bias as subjects were women who presented to the gynaecology clinic or accompanied their daughter to a gynaecology clinic for a gynaecological problem. The results may not be generalised to the whole population of Hong Kong. Second, the questionnaire was not validated and the questions did not include all aspects of the use of COC pills. Third, we relied on women’s self-reported use of COC pills and could not verify the information. Despite these, the questionnaire included the most widely studied aspects of non-contraceptive benefits and risks of the COC pill and knowledge score or uncertainty score have been used in previous literature.15 16 Although this study was conducted in only one centre and in Chinese women only, it helps clinicians to understand the low levels of acceptance of and compliance with prescribed COC pills.
 
The degree of misconception among Hong Kong mothers about COC use is of concern. Hong Kong has a well-developed education system with many highly regarded universities. The reported limited sex education in schools may be responsible for this knowledge gap of Hong Kong mothers.13 This may in turn have an impact on the advice they give their daughters, who are usually compliant with their mother’s wishes. Specific training in communication and counselling skills should be provided to health care professionals when promoting sexual health to women and adolescents.34
 
Conclusions
Our study found that the Hong Kong Chinese women who attended a gynaecology clinic of a tertiary centre had a low acceptance rate of the use of COC pills by their daughters. This low acceptance was associated with a lack of knowledge and misconception of the risks and benefits of the COC pills. Such ignorance will exert an adverse influence on the choice of treatment for many gynaecological problems in teenage daughters.
 
Declaration
All authors have disclosed no conflicts of interest.
 
References
1. Vessey M, Painter R. Oral contraceptive use and cancer. Findings in a large cohort study, 1968-2004. Br J Cancer 2006;95:385-9. CrossRef
2. Proctor ML, Roberts H, Farquhar CM. Combined oral contraceptive pill (OCP) as treatment for primary dysmenorrhoea. Cochrane Database Syst Rev 2001;(4):CD002120.
3. Nader S, Diamanti-Kandarakis E. Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis. Hum Reprod 2007;22:317-22. CrossRef
4. Chan SS, Yiu KW, Yuen PM, Sahota DS, Chung TK. Menstrual problems and health-seeking behaviour in Hong Kong Chinese girls. Hong Kong Med J 2009;15:18-23.
5. Chung PW, Chan SS, Yiu KW, Lao TT, Chung TK. Menstrual disorders in a Paediatric and Adolescent Gynaecology Clinic: patient presentations and longitudinal outcomes. Hong Kong Med J 2011;17:391-7.
6. Esmaelizadeh S, Delavar MA, Amiri M, Khafri S, Pasha NG. Polycystic ovary syndrome in Iranian adolescents. Int J Adolesc Med Health 2014;26:559-65. CrossRef
7. Christensen SB, Black MH, Smith N, et al. Prevalence of polycystic ovary syndrome in adolescents. Fertil Steril 2013;100:470-7. CrossRef
8. Wang C. Trends in contraceptive use and determinants of choice in China: 1980-2010. Contraception 2012;85:570-9. CrossRef
9. Lo SS, Fan SY. Acceptability of the combined oral contraceptive pill among Hong Kong women. Hong Kong Med J 2016;22:231-6.
10. The Family Planning Association of Hong Kong. 2014-2015 Annual report. Available from: http://www.famplan.org.hk/fpahk/en/template1.asp?style=template1.asp&content=about/annualreport.asp. Accessed 28 Apr 2016.
11. The Family Planning Association of Hong Kong. Youth sexuality in Hong Kong secondary school survey. Available from: http://www.famplan.org.hk/fpahk/en/template1.asp?content=info/research.asp. Accessed 28 Apr 2016.
12. Che FS. A study of the implementation of sex education in Hong Kong secondary schools. Sex Educ 2005;5:281-94. CrossRef
13. Survey of life skills-based education on HIV/AIDS at junior level of secondary schools in Hong Kong. Red Ribbon Centre, Department of Health, Hong Kong SAR Government; 2014.
14. Wong WC, Lee A, Tsang KK, Lynn H. The impact of AIDS/sex education by schools or family doctors on Hong Kong Chinese adolescents. Psychol Health Med 2006;11:108-16. CrossRef
15. Voqt C, Schaefer M. Disparities in knowledge and interest about benefits and risks of combined oral contraceptives. Eur J Contracept Reprod Health Care 2011;16:183-93. CrossRef
16. Lim HJ, Lee MS, Cho YH, Kazumi U. A comparative study of knowledge about and attitudes toward the combined oral contraceptives among Korean and Japanese university students. Pharmacoepidemiol Drug Saf 2004;13:741-7. CrossRef
17. Bachar R, Yogev Y, Fisher M, Geva A, Blumberg G, Kaplan B. Attitudes of mothers toward their daughters’ use of contraceptives in Israel. Contraception 2002;66:117-20. CrossRef
18. Chan SS, Cheung TH, Lo WK, Chung TK. Women’s attitudes on human papillomavirus vaccination to their daughters. J Adolesc Health 2007;41:204-7. CrossRef
19. Cibula D, Gompel A, Mueck AO, et al. Hormonal contraception and risk of cancer. Hum Reprod Update 2010;16:631-50. CrossRef
20. Bitzer J. Oral contraceptives in adolescent women. Best Pract Res Clin Endocrinol Metab 2013;27:77-89. CrossRef
21. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 1996;347:1713-27. CrossRef
22. Charlton BM, Rich-Edwards JW, Colditz GA, et al. Oral contraceptive use and mortality after 36 years of follow-up in the Nurses’ Health Study: prospective cohort study. BMJ 2014;349:g6356. CrossRef
23. Burkman R, Schlesselman JJ, Zieman M. Safety concerns and health benefits associated with oral contraception. Am J Obstet Gynecol 2004;190 (4 Suppl):S5-22. CrossRef
24. Mansour D, Gemzell-Dianielsson K, Inki P, Jensen JT. Fertility after discontinuation of contraception: a comprehensive review of the literature. Contraception 2011;84:465-77. CrossRef
25. Guillebaud J, MacGregor A. Contraception: your questions answered. 6th ed. London: Churchill Livingstone; 2013.
26. Gallo MF, Lopez LM, Grimes DA, Carayon F, Schulz KF, Helmerhorst FM. Combination contraceptives: effects on weight. Cochrane Database Syst Rev 2014;(1):CD003987. CrossRef
27. Saluja G, Iachan R, Scheidt PC, Overpeck MD, Sun W, Giedd JN. Prevalence of and risk factors for depressive symptoms among young adolescents. Arch Pediatr Adolesc Med 2004;158:760-5. CrossRef
28. Walker A, Bancroft J. Relationship between premenstrual symptoms and oral contraceptive use: a controlled study. Psychosom Med 1990;52:86-96. CrossRef
29. Rosenthal SL, Cotton S, Ready JN, Potter LS, Succop PA. Adolescents’ attitudes and experiences regarding levonorgestrel 100 mcg/ethinyl estradiol 20 mcg. J Pediatr Adolesc Gynecol 2002;15:301-5. CrossRef
30. Lee WS, Kim KI, Lee HJ, Kyung HS, Seo SS. The incidence of pulmonary embolism and deep vein thrombosis after knee arthroplasty in Asians remains low: a meta-analysis. Clin Orthop Relat Res 2013;471:1523-32. CrossRef
31. Vinogradova Y, Coupland C, Hippisley-Cox J. Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ 2015;350:h2135. CrossRef
32. Zöller B, Ohlsson H, Sundquist J, Sundquist K. Family history of venous thromboembolism is a risk factor for venous thromboembolism in combined oral contraceptive users: a nationwide case-control study. Thromb J 2015;13:34. CrossRef
33. Medical eligibility criteria for contraceptive use. 5th ed. Geneva: World Health Organization; 2015.
34. Yip BH, Sheng XT, Chan VW, Wong LH, Lee SW, Abraham AA. ‘Let’s talk about sex’—a knowledge, attitudes and practice study among paediatric nurses about teen sexual health in Hong Kong. J Clin Nurs 2015;24:2591-600. CrossRef